We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Molecular Analysis Tool to Improve Disease Diagnosis

By LabMedica International staff writers
Posted on 05 Nov 2025

Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional variations. More...

Traditional approaches like ELISA or mass spectrometry require labeling or complex processing and can miss minute molecular differences. Now, researchers have developed a label-free analytical method called voltage-matrix nanopore profiling, which can classify biomolecules based on their intrinsic electrical signatures.

The breakthrough by researchers from The University of Tokyo (Tokyo, Japan) combines multivoltage solid-state nanopore recordings with machine learning to create a multidimensional map of molecular signals. Their research, published in Chemical Science, demonstrate how this technique can identify and classify proteins in complex mixtures without modification, paving the way for next-generation molecular diagnostics.

Solid-state nanopores act as nanoscale tunnels through which individual molecules pass, driven by ionic current. By systematically varying the voltage, the team recorded how protein molecules interacted with the nanopores under different electrical conditions. These measurements formed a voltage matrix, which captured both stable and voltage-sensitive features of each molecule. Machine learning algorithms then analyzed these features to accurately classify and distinguish proteins, even when they were mixed together.

To validate their approach, the researchers analyzed mixtures containing two cancer-related biomarkers: carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3). Using six voltage conditions, they constructed distinct signal patterns that reliably differentiated each protein. The technique also detected molecular changes when CEA bound with an aptamer—a short, synthetic DNA sequence—demonstrating its sensitivity to subtle structural alterations.

In another test using mouse serum samples, the voltage-matrix framework successfully distinguished between centrifuged and non-centrifuged sera, confirming its potential for real-world diagnostic use. The method revealed compositional differences invisible to conventional single-voltage nanopore measurements, underscoring its ability to uncover molecular diversity in complex biological fluids.

By integrating physics, nanotechnology, and artificial intelligence, this new analytical framework offers a powerful tool for understanding molecular individuality—the unique electrical signature of each molecule. It holds promise for biomedical applications ranging from disease diagnosis to environmental monitoring, providing a foundation for high-resolution, real-time molecular profiling.

“By systematically varying voltage conditions and applying machine learning, we can create a voltage matrix that reveals both robust, voltage-independent molecular features and voltage-sensitive structural changes,” said Professor Sotaro Uemura. “Our study is not simply about improving detection sensitivity — it establishes a new way to represent and classify molecular signals across voltages, allowing us to visualize molecular individuality and estimate compositions within mixtures.”

Related Links:
The University of Tokyo


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Noul’s AI-based cervical cancer diagnostic solution, miLab CER (Photo courtesy of Noul)

AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America

Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.